Updates to the Handbook

Updates to guidance provided in 'Types of vaccines' to include information regarding mRNA and viral vector vaccines (as used in the development of some COVID-19 vaccines).

Minor update to guidance on co-administration of Vaxelis vaccine with other vaccines.

Updates to guidance on the co-administration of Vaxelis with other vaccines.

Minor update to guidance on co-administration of Vaxelis vaccine with other vaccines.

Minor update to guidance on co-administration of Vaxelis vaccine with other vaccines.

Updates to guidance on co-administration of Vaxelis vaccine with other vaccines.

Minor update to guidance on co-administration of Vaxelis vaccine with other vaccines.

Updates throughout the chapter to reflect the addition of the hexavalent Vaxelis vaccine on the National Immunisation Program.

Updates throughout the chapter to reflect the introduction of the hexavalent Vaxelis vaccines on the National Immunisation Program.

Additional detail also provided in the Epidemiology section of the chapter.

Updates throughout the chapter to reflect introduction of hexavalent Vaxelis vaccine on the National Immunisation Program.

Additionally, updates made to the Epidemiology section of the chapter.

Updates to recommendations and information on National Immunisation Program funded vaccines to reflect GRADE assessment of meningococcal vaccines.

Updated List. Specified medical conditions associated with increased risk of invasive meningococcal disease.

Updates to Variations from product information section for Bexsero.

Updates throughout the chapter to reflect the introduction of the hexavalent Vaxelis vaccine to the National Immunisation Program.

Additionally, updates made to the Epidemiology section of the chapter.

Updates throughout the chapter to reflect the introduction of hexavalent Vaxelis vaccine on the National Immunisation Program.

Updates made to the Epidemiology section.

Updates to Table. Components of vaccines used in Australia to reflect introduction of Vaxelis vaccine and amend ingredients for existing vaccines.

Updates throughout the chapter to reflect the introduction of the hexavalent Vaxelis vaccine on the National Immunisation Program.

Additionally, updates also made to the Epidemiology section.

Updates to clinical guidance for Hib vaccine to reflect the introduction of hexavalent Vaxelis vaccine. 

Updates to clinical guidance throughout the chapter to improve clarity and provide further guidance regarding injection sites, positioning for vaccination, vaccine injection techniques, distraction techniques, use of vaccines in multidose vials, giving multiple vaccine injections at the same visit.

Updates throughout the chapter to improve clarity of information and provide up-to-date guidance.

Updates to Epidemiology section to provide the most up-to-date information.

Updates to guidance in NHIG as prophylaxis in Public Health Management section to reflect most up-to-date information.